A compelling genetic hypothesis for a complex disease: PRODH2/DGCR6 variation leads to schizophrenia susceptibility.
Chakravarti
Aravinda
A
McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. aravinda@jhmi.edu
D000818:Animals; D002892:Chromosomes, Human, Pair 22; D016326:Extracellular Matrix Proteins; D020022:Genetic Predisposition to Disease; D006801:Humans; D051379:Mice; D009687:Nuclear Proteins; D011110:Polymorphism, Genetic; D011394:Proline Oxidase / Q000235:genetics*; D011506:Proteins / Q000235:genetics*; D012559:Schizophrenia / Q000235:genetics*
C101273:DGCR6 protein, human; C498400:Dgcr6 protein, mouse; D016326:Extracellular Matrix Proteins; D009687:Nuclear Proteins; D011506:Proteins; D011394:Proline Oxidase; C452185:proline dehydrogenase (oxidase) 2